SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-23-020321
Filing Date
2023-01-31
Accepted
2023-01-31 16:03:36
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B3 d374646d424b3.htm 424B3 3570564
2 GRAPHIC g374646g01b17.jpg GRAPHIC 53162
3 GRAPHIC g374646g01r16.jpg GRAPHIC 117201
4 GRAPHIC g374646g01r17.jpg GRAPHIC 101891
5 GRAPHIC g374646g03a01.jpg GRAPHIC 772899
6 GRAPHIC g374646g07a01.jpg GRAPHIC 667214
7 GRAPHIC g374646g07b01.jpg GRAPHIC 670982
8 GRAPHIC g374646g12a01.jpg GRAPHIC 685961
9 GRAPHIC g374646g13g01.jpg GRAPHIC 82860
10 GRAPHIC g374646g15a01.jpg GRAPHIC 76759
11 GRAPHIC g374646g15b01.jpg GRAPHIC 73407
12 GRAPHIC g374646g15c03.jpg GRAPHIC 582091
13 GRAPHIC g374646g21a01.jpg GRAPHIC 581067
  Complete submission text file 0001193125-23-020321.txt   9671012
Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Filer) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-268888 | Film No.: 23572537
SIC: 2834 Pharmaceutical Preparations